Serum Institute picks up 50% in glass vial maker Schott's Indian JV

Deal value not disclosed; former co-promoters Kaisha exits JV

Vaccine maker Serum Institute of India (SII) has picked up a 50 per cent stake in specialty glass company Schott AG’s Indian joint venture, Schott Kaisha, from the former co-owners Kairus Dadachanji and Shapoor Mistry for an undisclosed sum.

While the deal helps SII to have more control over its supply chain (glass vials are a critical component of vaccine packaging), it also helps the Kaisha group to focus on their other pharmaceutical ventures.

Sources in the know say that now Dadachanji and Mistry would focus on bringing in new pharmaceutical products – both drugs and drug delivery systems –